133 related articles for article (PubMed ID: 18474217)
1. Down-modulation of B cell signal transduction by ligation of mucins to CD22.
Toda M; Akita K; Inoue M; Taketani S; Nakada H
Biochem Biophys Res Commun; 2008 Jul; 372(1):45-50. PubMed ID: 18474217
[TBL] [Abstract][Full Text] [Related]
2. Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells.
Toda M; Hisano R; Yurugi H; Akita K; Maruyama K; Inoue M; Adachi T; Tsubata T; Nakada H
Biochem J; 2009 Feb; 417(3):673-83. PubMed ID: 18925876
[TBL] [Abstract][Full Text] [Related]
3. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
[TBL] [Abstract][Full Text] [Related]
4. SLP-76 is recruited to CD22 and dephosphorylated by SHP-1, thereby regulating B cell receptor-induced c-Jun N-terminal kinase activation.
Mizuno K; Tagawa Y; Watanabe N; Ogimoto M; Yakura H
Eur J Immunol; 2005 Feb; 35(2):644-54. PubMed ID: 15668918
[TBL] [Abstract][Full Text] [Related]
5. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
Tedder TF; Poe JC; Haas KM
Adv Immunol; 2005; 88():1-50. PubMed ID: 16227086
[TBL] [Abstract][Full Text] [Related]
6. A distinct signaling pathway used by the IgG-containing B cell antigen receptor.
Wakabayashi C; Adachi T; Wienands J; Tsubata T
Science; 2002 Dec; 298(5602):2392-5. PubMed ID: 12493916
[TBL] [Abstract][Full Text] [Related]
7. Phosphatase inhibition augments anti-CD22-mediated signaling and cytotoxicity in non-hodgkin's lymphoma cells.
O'Donnell RT; Pearson D; McKnight HC; Ma YP; Tuscano JM
Leuk Res; 2009 Jul; 33(7):964-9. PubMed ID: 19237192
[TBL] [Abstract][Full Text] [Related]
8. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling.
Gerlach J; Ghosh S; Jumaa H; Reth M; Wienands J; Chan AC; Nitschke L
Eur J Immunol; 2003 Dec; 33(12):3418-26. PubMed ID: 14635051
[TBL] [Abstract][Full Text] [Related]
9. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
Horikawa K; Martin SW; Pogue SL; Silver K; Peng K; Takatsu K; Goodnow CC
J Exp Med; 2007 Apr; 204(4):759-69. PubMed ID: 17420266
[TBL] [Abstract][Full Text] [Related]
10. Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding.
Nitschke L; Lajaunias F; Moll T; Ho L; Martinez-Soria E; Kikuchi S; Santiago-Raber ML; Dix C; Parkhouse RM; Izui S
Int Immunol; 2006 Jan; 18(1):59-68. PubMed ID: 16291654
[TBL] [Abstract][Full Text] [Related]
11. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
Nitschke L
Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
[TBL] [Abstract][Full Text] [Related]
12. Expansion of CD22lo B cells in the spleen of autoimmune-prone flaky skin mice.
Mattsson N; Duzevik EG; Pelsue SC
Cell Immunol; 2005 Apr; 234(2):124-32. PubMed ID: 16054613
[TBL] [Abstract][Full Text] [Related]
13. CD22 serves as a receptor for soluble IgM.
Adachi T; Harumiya S; Takematsu H; Kozutsumi Y; Wabl M; Fujimoto M; Tedder TF
Eur J Immunol; 2012 Jan; 42(1):241-7. PubMed ID: 21956693
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival.
Ferry H; Crockford TL; Silver K; Rust N; Goodnow CC; Cornall RJ
Eur J Immunol; 2005 Dec; 35(12):3655-63. PubMed ID: 16278813
[TBL] [Abstract][Full Text] [Related]
15. B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity.
Fujimoto M; Sato S
J Dermatol Sci; 2007 Apr; 46(1):1-9. PubMed ID: 17223015
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
Mihaylova N; Voynova E; Tchorbanov A; Dolashka-Angelova P; Bayry J; Devreese B; Kaveri S; Vassilev T
Mol Immunol; 2009 Nov; 47(1):123-30. PubMed ID: 19243823
[TBL] [Abstract][Full Text] [Related]
17. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
[TBL] [Abstract][Full Text] [Related]
18. The role of CD22 and other inhibitory co-receptors in B-cell activation.
Nitschke L
Curr Opin Immunol; 2005 Jun; 17(3):290-7. PubMed ID: 15886119
[TBL] [Abstract][Full Text] [Related]
19. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.
Poe JC; Fujimoto Y; Hasegawa M; Haas KM; Miller AS; Sanford IG; Bock CB; Fujimoto M; Tedder TF
Nat Immunol; 2004 Oct; 5(10):1078-87. PubMed ID: 15378059
[TBL] [Abstract][Full Text] [Related]
20. CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity.
Chen J; McLean PA; Neel BG; Okunade G; Shull GE; Wortis HH
Nat Immunol; 2004 Jun; 5(6):651-7. PubMed ID: 15133509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
